Adaptimmune Therapeutics
ADAP
#9324
Rank
โ‚ฌ60.56 M
Marketcap
0,24ย โ‚ฌ
Share price
-20.31%
Change (1 day)
-81.36%
Change (1 year)

Adaptimmune Therapeutics (ADAP) - Cash on Hand

Cash on Hand as of December 2024 : โ‚ฌ0.13 Billion

According to Adaptimmune Therapeutics's latest financial reports the company has โ‚ฌ0.13 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Adaptimmune Therapeutics - Cash on Hand chart (from 2014 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚ฌ0.13 B-30.31%
2022-12-31โ‚ฌ0.19 B-41.55%
2021-12-31โ‚ฌ0.32 B9.01%
2020-12-31โ‚ฌ0.29 B274.53%
2019-12-31โ‚ฌ79.93 M-55.42%
2018-12-31โ‚ฌ0.17 B3.31%
2017-12-31โ‚ฌ0.17 B0.61%
2016-12-31โ‚ฌ0.17 B
2015-06-30โ‚ฌ0.25 B574.2%
2014-06-30โ‚ฌ37.57 M19630.2%
2013-06-30โ‚ฌ0.19 M-92.03%
2012-06-30โ‚ฌ2.38 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚ฌ0.84 B 508.90%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ36.75 M-73.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.33 B 142.42%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
โ‚ฌ1.01 B 633.01%๐Ÿ‡บ๐Ÿ‡ธ USA